7nr8: Difference between revisions
Jump to navigation
Jump to search
m Protected "7nr8" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 7nr8 is ON HOLD | The entry 7nr8 is ON HOLD until Paper Publication | ||
Authors: O'Reilly, M., Cleasby, A. | Authors: O'Reilly, M., Cleasby, A. | ||
| Line 7: | Line 7: | ||
Description: Discovery of ASTX029, a clinical candidate which modulates the phosphorylation and catalytic activity of ERK1/2 | Description: Discovery of ASTX029, a clinical candidate which modulates the phosphorylation and catalytic activity of ERK1/2 | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
[[Category: Cleasby, A]] | |||
[[Category: O'Reilly, M]] | [[Category: O'Reilly, M]] | ||
Revision as of 12:30, 31 March 2021
Unreleased structure
The entry 7nr8 is ON HOLD until Paper Publication
Authors: O'Reilly, M., Cleasby, A.
Description: Discovery of ASTX029, a clinical candidate which modulates the phosphorylation and catalytic activity of ERK1/2